Chronic Renal Failure Clinical Trials

7 recruiting

Chronic Renal Failure Trials at a Glance

11 actively recruiting trials for chronic renal failure are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Alexandroupoli, Beijing, and Belo Horizonte. Lead sponsors running chronic renal failure studies include Brugmann University Hospital, Dr Tilenka Thynne, and Athens LifeTech Park.

Browse chronic renal failure trials by phase

Treatments under study

About Chronic Renal Failure Clinical Trials

Looking for clinical trials for Chronic Renal Failure? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Chronic Renal Failure trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Chronic Renal Failure clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

Study of Patient Preferences in Dialysis Treatment Choice: a Discrete Choice Experiment

End Stage Chronic Renal Failure
University Hospital, Caen500 enrolled2 locationsNCT07535320
Recruiting
Not Applicable

Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage

Chronic Kidney Disease (Stages 4 and 5)Kidney Transplantation RecipientsEnd Stage Chronic Renal Failure
Vanderbilt University Medical Center30 enrolled1 locationNCT07385651
Recruiting
Not Applicable

Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.

End Stage Chronic Renal Failure
Oman Ministry of Health38 enrolled1 locationNCT07491042
Recruiting
Not Applicable

The Solaris DE Endoprosthesis for the Treatment of AV Access Stenosis or Occlusion

Chronic Renal FailureVenous StenosisVenous Occlusion
Scitech Produtos Medicos SA120 enrolled5 locationsNCT06096142
Recruiting
Phase 2

A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.

Chronic Kidney Disease Stage 3Chronic Renal FailureMechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis+1 more
Klinikum Nürnberg100 enrolled2 locationsNCT05884866
Recruiting

Observational Study of the Use of Extraneal in Peritoneal Dialysis in Patients

Chronic Renal Failure
Vantive Health LLC889 enrolled10 locationsNCT06492031
Recruiting
Not Applicable

Evaluation of Endothelial Dysfunction Using the "Flow Mediated Dilation" Test in a Population of Chronic Renal Failure Patients at Different Stages, and Evaluation of the Role of Antiphospholipid Antibodies

Chronic Renal Failure
Brugmann University Hospital200 enrolled1 locationNCT06347029
Recruiting

A Clinical Study to Map the HLA Genomic Region in the Greek Population

Cardiovascular DiseasesMetabolic DiseaseHealthy+7 more
Athens LifeTech Park12,000 enrolled8 locationsNCT06227468
Recruiting
Not Applicable

Coronary Rotational Atherectomy Elective vs. Bailout in Severely Calcified Lesions and Chronic Renal Failure

Coronary Artery DiseaseChronic Renal Failure
Guillermo Galeote; MD, PhD124 enrolled1 locationNCT05353946
Recruiting

Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children

Turner SyndromeChronic Renal FailureGrowth Hormone Deficiency+2 more
LG Chem6,000 enrolled1 locationNCT01604395
Recruiting
Phase 2

Investigation of whether metformin can be used safely and effectively in patients with type 2 diabetes on haemodialysis

Chronic Renal failure on haemodialysisType 2 Diabetes
Dr Tilenka Thynne6 enrolled1 locationACTRN12612000352808